Literature DB >> 6232833

Effect of single oral doses of prednisone and deflazacort on human lymphocyte distribution and functions. Analysis with monoclonal antibodies.

M Scudeletti, D Pende, A Barabino, B Imbimbo, V Grifoni, F Indiveri.   

Abstract

Two corticosteroids, prednisone and deflazacort, have been compared with respect to their capacity of inducing redistribution of T lymphocyte subsets, modification of expression of Ia antigens by PHA primed T cells, and inhibition of blastogenesis of T cells in autologous mixed lymphocyte reactions. Both corticosteroids were able to induce T lymphocytes depletion, increase of suppressor T cells, inhibit Ia expression upon mitogenic activation of T lymphocytes, and inhibit autologous MLRs either when non T cells or when PHA T lymphocytes were used as stimulators. We conclude that deflazacort may constitute a better glucocorticoid than prednisone for correcting the imbalance among T cells subsets, the helper T cells activity and the processes of cell-to-cell cooperation in immune diseases.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6232833

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  6 in total

1.  Deflazacort versus other glucocorticoids: a comparison.

Authors:  Surajit Nayak; Basanti Acharjya
Journal:  Indian J Dermatol       Date:  2008       Impact factor: 1.494

Review 2.  The effect of aging on host defences. Implications for therapy.

Authors:  A Scordamaglia; G Ciprandi; F Indiveri; G W Canonica
Journal:  Drugs Aging       Date:  1991 Jul-Aug       Impact factor: 3.923

Review 3.  Deflazacort. A review of its pharmacological properties and therapeutic efficacy.

Authors:  A Markham; H M Bryson
Journal:  Drugs       Date:  1995-08       Impact factor: 9.546

4.  Comparison of two glucocorticoid preparations (deflazacort and prednisone) in the treatment of immune-mediated diseases.

Authors:  M Scudeletti; F Puppo; L Lanza; L Mantovani; O Bosco; A Iudice; B Imbimbo; F Indiveri
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

5.  Deflazacort in comparison to other steroids for nephrotic syndrome.

Authors:  K R Jat; A Khairwa
Journal:  Indian J Nephrol       Date:  2012-07

6.  Deflazacort induced stronger immunosuppression than expected.

Authors:  Rocio E Gonzalez-Castañeda; Estela Adriana Castellanos-Alvarado; Maria Rosa Flores-Marquez; Oscar Gonzalez-Perez; Sonia Luquin; Joaquin Garcia-Estrada; Cesar Ramos-Remus
Journal:  Clin Rheumatol       Date:  2007-06       Impact factor: 3.650

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.